Results 171 to 180 of about 5,464 (192)

Different effects of abciximab and cytochalasin D on clot strength in thrombelastography

Journal of Thrombosis and Haemostasis, 2004
H Metzler
exaly  

[Abciximab].

Nihon rinsho. Japanese journal of clinical medicine, 2007
Kenji, Yokoyama, Yasuo, Ikeda
openaire   +3 more sources

Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug

Journal of Thrombosis and Haemostasis, 2004
B R Curtis, R H Aster
exaly  

Abciximab

Reactions Weekly, 2020
openaire   +1 more source

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial

Stroke, 2008
Mark B Effron, James Torner, Philip Teal   +2 more
exaly  

Benefits From Small Molecule Administration as Compared With Abciximab Among Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Angioplasty

Journal of the American College of Cardiology, 2009
Giuseppe De Luca, Ettore Cassetti, Paolo Marino   +2 more
exaly  

Acute Profound Thrombocytopenia After c7E3 Fab (Abciximab) Therapy

Circulation, 1997
Scott D Berkowitz, Robert A Harrington, J E Tcheng   +2 more
exaly  

Cryo-Electron Microscopy Structure of the αIIbβ3-Abciximab Complex

Arteriosclerosis, Thrombosis, and Vascular Biology, 2020
Yixiao Zhang, Aleksandar Spasic, Davide Provasi   +2 more
exaly  

Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial

Lancet, The, 2012
Holger Thiele, Jochen Wöhrle, Harald Rittger   +2 more
exaly  

ABCIXIMAB

Neurology Today, 2005
openaire   +1 more source